Skip to content
Dx

ICD-10-CM 2027 diagnosis code

C83.39Diffuse large B-cell lymphoma, extranodal and solid organ sites

Not billable — use a more specific code

C83.39 is a header code, so it can't be reported by itself. Choose one of the 2 more specific codes beneath it.Short description: Diffuse large B-cell lymphoma, extrnod and solid organ sites

Code last changed in FY2025 (effective October 1, 2024). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About C83.39

C83.39 is the ICD-10-CM diagnosis code for diffuse large B-cell lymphoma, extranodal and solid organ sites. It belongs to category C83 (non-follicular lymphoma), block C81-C96 (malignant neoplasms of lymphoid, hematopoietic and related tissue) and chapter 2 (neoplasms). It is a header code, so it can't be reported by itself; one of its 2 subcodes must be used instead.

Within C83.3 (diffuse large B-cell lymphoma), C83.39 is specifically for diffuse large B-cell lymphoma, extranodal and solid organ sites. Related codes cover unspecified site (C83.30), lymph nodes of head, face, and neck (C83.31), intrathoracic lymph nodes (C83.32), intra-abdominal lymph nodes (C83.33), lymph nodes of axilla and upper limb (C83.34), lymph nodes of inguinal region and lower limb (C83.35), intrapelvic lymph nodes (C83.36), spleen (C83.37) and 2 more.

To report this condition, pick the subcode that matches the documentation: C83.390 (lymphoma) and C83.398 (sites).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015, and changed in FY2025 (expanded into subcodes).

Before ICD-10, this condition was coded in ICD-9-CM as 200.00 (reticulosarcoma, unspecified site, extranodal and solid organ sites), 200.50 (primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites) and 200.70 (large cell lymphoma, unspecified site, extranodal and solid organ sites).

Specific codes under C83.39

Notes that apply from higher levels

Instructions written at a parent level also apply to C83.39.

› From C83.3 Diffuse large B-cell lymphoma
Excludes1
  • mediastinal (thymic) large B-cell lymphoma (C85.2-)
  • mature T/NK-cell lymphomas (C84.-)
› From C83 Non-follicular lymphoma
Excludes1
  • personal history of non-Hodgkin lymphoma (Z85.72)

Broader instructions also apply from C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue and Chapter 2: Neoplasms.

ICD-9-CM equivalent

Converter →
  • 200.00Reticulosarcoma, unspecified site, extranodal and solid organ sitesapproximate
  • 200.50Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sitesapproximate
  • 200.70Large cell lymphoma, unspecified site, extranodal and solid organ sitesapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • FY2025 (effective 10/1/2024): Expanded — no longer billable

Common questions about C83.39

Is C83.39 billable?

No. C83.39 is a header code. Report one of its more specific subcodes instead.

What is the ICD-9 code for C83.39?

The CMS General Equivalence Mappings map C83.39 to ICD-9-CM 200.00, 200.50 and 200.70.